Sort
53,477 grants matching “addiction”
Low-input profiling of brain-region and cell-type specific epigenomic dynamics to understand gene-environment interactions in opioid addiction
$732,324Chang Lu · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · DA
Identification of synthetic lethal interactors in pancreatic cancer
$732,247Channing J Der · Univ Of North Carolina Chapel Hill · U01 · FY2016 · CA
Inter-Temporal Trade-offs in the Risky Decisions of Cocaine Addicts
$732,228Warren K Bickel · Virginia Polytechnic Inst And St Univ · R01 · FY2012 · DA
Imaging sex differences in smoking-induced dopamine release via novel PET methods
$731,997Evan D Morris · Yale University · R01 · FY2016 · DA
Drug Abuse Training Program
$731,894Jacqueline F. McGinty · Medical University Of South Carolina · T32 · FY2019 · DA
sEH Inhibitors to Treat Neuropathic Pain
$731,876Alan R Buckpitt · Eicosis, Llc · R44 · FY2016 · ES
Development and Evaluation of Video-Based Directly Observed Therapy for Office-Based Treatment of Opioid Use Disorders with Buprenorphine
$731,871Sebastian Seiguer · Emocha Mobile Health, Inc. · R44 · FY2018 · DA
Research Support Core D: Clinical and Behavioral Services
$731,866Ann K Avery · Case Western Reserve University · P30 · FY2023 · DA
Research Support Core D: Clinical and Behavioral Services
$731,866Ann K Avery · Case Western Reserve University · P30 · FY2022 · DA
Research Support Core D: Clinical and Behavioral Services
$731,866Ann K Avery · Case Western Reserve University · P30 · FY2024 · DA
Molecular mechanisms of memory maintenance and dysfunction in neural circuits
$731,684Todd C Sacktor · Suny Downstate Medical Center · R01 · FY2019 · MH
A Randomized Controlled Trial and Cohort Study of HIV Testing and Linkage to Care
$731,641Michael Scott Gordon · Friends Research Institute, Inc. · R01 · FY2011 · DA
Addictions treatment organizational response to COVID-19: impact on disparities in quality of care
$731,602Charles J Neighbors · New York University School Of Medicine · R01 · FY2023 · DA
Evaluation of Clinical Effectiveness, Cost, and Implementation Factors to Optimize Scalability of Treatment for Co-Occurring SUD and PTSD Among Teens
$731,580Carla Kmett Danielson · Medical University Of South Carolina · R01 · FY2022 · DA
Methodology and measurement for examining short-term and long-term effects of e-cigarette and polysubstance use
$731,536Yuh-Pey Anne Buu · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · DA
Rapid response human testing of smokeless tobacco products
$731,510Pamela I Clark · Univ Of Maryland, College Park · R01 · FY2014 · DA
PTSD and Addiction Disorder Screening and Treatment for Incarcerated Men
$731,468Nancy Wolff · Rutgers, The State Univ Of N.J. · R01 · FY2011 · MH
Parallel Multimodal High-throughput screening to identify activators of the orexin receptors
$731,424Theodore M Kamenecka · Scripps Florida · R01 · FY2020 · MH
Essential Fatty Acids In Psychiatric Disorders
$731,401Joseph Hibbeln · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
Blood Donor Competence, Autonomy and Relatedness Enhancement (Blood Donor CARE)
$731,352Christopher R France · Ohio University Athens · R01 · FY2017 · HL
Supporting Treatment Access and Recovery in Re-entry (STAR-R)
$731,275David A Smelson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · DA
Ending the HIV Epidemic: Peer-supported collaborative care for mental health and substance use disorder care integration into HIV care settings
$731,201Oluwaseun Falade-Nwulia · Johns Hopkins University · R01 · FY2020 · DA
Neurobehavioral Determinants of Adolescent Substance Use and HIV/STD Behaviors
$731,183Jungmeen Kim · Virginia Polytechnic Inst And St Univ · R01 · FY2013 · DA
Drug Dependence Clinical Research Program
$731,167Reese T. Jones · University Of California, San Francisco · P30 · FY2018 · DA
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse
$730,959Joan Weinberger Berman · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · DA